Themes identified: 1. Understanding DR and the purpose of screening 2. Complex factors that influence non-attendance 3. Confusion between formal DR screening and ad hoc screening in optometrists 4. Patient responsibility 5. Easy access to screening 6. Experience of screening -drops and waiting times Discussion:
They have identified a number of factors. Have any other studies identify these factors or contradict the findings or have develop interventions to overcome these factors Should look at each finding as per the results For example the discussion is weak about the side effects of mydriasis (what drops do they use tropicamide+/-phenyephrine.
Could they alter what they use (tropicamide 0.5%) is associated with less stinging. There is some studies on this. What about using no mydriasis? Pros and cons for that. I don"t know the stinging is due to the osmotic effects of the drops (reference) Strengths and limitations are correct.
"Several providers now deliver DRS in the UK, and, since this research was conducted, Public Health England is responsible for delivery; the 2014/15 Quality Outcomes Framework now excludes the DRS indicator. This fast-moving field requires monitoring closely. Building on the successful central appointments system and practice factors that affect DRS attendance (33), may prove useful. The national implementation of the new screening pathway should ensure consistent delivery throughout the country, improving the quality of services and reducing variability (32)." "This study uses staff and patients" experiences of Diabetic Retinopathy Screening to start unpicking factors affecting uptake rates. The successful implementation of the new care pathway should ensure proactive care coordination and consistent strategies to identify and address unmet access needs before, during and after screening. Clear guidance from professional bodies, a Public Health media campaign to encourage positive attitudes, and reformulated mydriasis drops, may improve DRS attendance. Used as an international model, this may, in turn, contribute to reducing preventable vision loss globally and its associated costs to individuals and their families, and to primary, secondary and social care providers" This study uses staff and patients" experiences of Diabetic Retinopathy Screening to start unpicking factors affecting uptake rates which are…. These factors should be addressed in the development and implementation of a new care pathway.
"Clear guidance from professional bodies, a Public Health media campaign to encourage positive attitudes, and reformulated mydriasis drops, may improve DRS attendance" You cannot conclude this as you did not study this. These are possible interventions to your identified factors.
REVIEWER
Michael Summerfield Georgetown University/Washington Hospital Center, USA REVIEW RETURNED 10-Jun-2014
GENERAL COMMENTS
May be interesting to include specific set of questions that were asked of patients included in this study as a supplemental figure. would recommend including in your discussion section of the paper, differences that were noted by patients in regards to screening at GP vs. optometrist practices (e.g. time of appt, ease of making appt, drops, etc)
Obviously, as the authors point out, this study includes a small subgroup of diabetic patients and only includes certain types of care settings. Also, there is a very high specialist/screener to patient ratio in this study. I would recommend that in your discussion section, you translate your results to include how they relate to real-world screening programs.
REVIEWER

Paul Galsworthy
Heart of England Foundation Trust, Grading Centre -BSBC DESP REVIEW RETURNED 13-Jun-2014
GENERAL COMMENTS
I agree with the authors that the paper has the limitations expressed within the article. However in addition the study takes a very small sample size and as such only represents the views of a handful of people.
Nationally a similar exercise should be undertaken amongst programmes preferably at a National level to establish like for like data from region to region.
Much more work is needed is this field so I applaud the initial efforts of the author.
VERSION 1 -AUTHOR RESPONSE
REVIEWER 1 Abstract: Don"t need what is already know Page 2 first paragraph of the abstract We thank the reviewer for this suggestion; we have amended accordingly, deleting the first paragraph of the abstract Page 2 line 34. "The differing regional invitation methods and screening locations were discussed, with convenience and transport safety being over-riding considerations for patients. Short appointment times were preferred by patients, some of whom experienced severe side-effects from the mydriasis drops used to dilate their pupils." May read better as "The differing regional invitation methods and screening locations were discussed, with convenience and transport safety and short appointment times being over-riding considerations for patients. Some patients mentioned significant visual disturbance from the mydriasis drops as a deterrent to attendance. Page 2 Results section of Abstract We thank the reviewer for this suggestion to improve clarity and we have deleted and reworded as suggested; added the word "pain". Page 2 Conclusions section of Abstract We have added "the pharmacological reformulation of shorter-acting" mydriasis drops
Conclusion:
Not sure what proactive coordination of care means. Page 2: Conclusion of abstract We thank the reviewer for this suggestion to improve clarity and we have elaborated upon "proactive coordination of care" by adding "involving patients, primary care and the Screening Programmes"
Can"t really conclude that educational interventions or "improved drops" may improve uptake as you did not examine this.
What really can say is that multiple factors prior to, during and after screening are involved in the attendance and non-attendance for DR screening which include some of the above Page 2 Conclusion of abstract We thank the reviewer for highlighting this and we have added this wording and suggested that further research is necessary to see if intervention/shorter-acting mydriasis drops help increase uptake.
Introduction:
A bit long We have considered this perspective but feel that the introduction contains important contextual information underpinning our research. The introduction currently stands at under 500 words which is consistent with other published papers in this journal.
Page 3 (line 41) "Initially asymptomatic, this microvascular complication is associated with high blood glucose, high blood lipids, hypertension, smoking, non-attendance at screening, minority ethnicity (15, 16), duration of diabetes (17, 18) and existing diabetic retinopathy (19)" Don"t really need this sentence. high blood glucose, high blood lipids, hypertension, duration of diabetes is associated with the development of DR. I don"t think smoking is an independent risk factor. Vision loss is associated with non-attendance at screening, minority ethnicity not DR as such. Can start the paragraph with "Adequate diabetes control, regular screening and timely laser treatment can prevent visual impairment (1, 14)." Page 3, paragraph 2 of Introduction We have removed this sentence as per the reviewer"s suggestion.
Mydraisis means to dilate pupils so "Mydriasis drops dilate patients" pupils, affecting their vision for four to six hours" this could read "patients pupils are dilated" The side effects could be left to discussion. Last line of page 3 -first line of page 4 Thank you for this helpful suggestion; we have amended the start of this sentence -but left side effects in, as it contextualizes an important finding of the study.
Methods:
Well written (succinct and clear) We thank the reviewer for this comment.
Page 5 line 37. No theme was unique to either regular attenders, or non-regular attenders. Could put this in the results. It is an important finding highlighting the complex nature of why people do or do not attend appointments. Page 5-6. We thank the reviewer for this comment. We agree that this sentence may better fit in Results, so we have moved it to Results after the sample description before the first theme on page 6, adding R1"s comment about importance of this.
Discussion:
Have any other studies identify these factors or contradict the findings or have develop interventions to overcome these factors Page 11
We thank the reviewer for this suggestion, and to improve clarity and we have inserted that we"ve confirmed "previous findings" to make it clear that we are discussing our results in the context of the literature. Whilst we are aware that there are few evaluated/published and unpublished intervention and qualitative studies, the evidence that exists is discussed in relation to our own findings in the discussion.
Should look at each finding as per the results Discussion We agree that this is ideally how Findings should be Discussed; however, there is insufficient space within the prescribed word limit, so we have picked out the most salient results to discuss considered of greatest interest to the journal readership.
For example the discussion is weak about the side effects of mydriasis (what drops do they use tropicamide+/-phenyephrine.
Could they alter what they use (tropicamide 0.5%) is associated with less stinging. There is some studies on this. What about using no mydriasis? Pros and cons for that. I don"t know the stinging is due to the osmotic effects of the drops (reference) Page 13 Future Research We thank the reviewer for highlighting this. All programmes within the English Screening Programme perform 2-field mydriatic photography. There is no option in the English Programme not to dilate. Scotland have a three stage screening procedure and dilate those that have poor quality images which amounts to about 34%. Those who one can get good quality images in without mydriasis tend to be younger people and so Northern Ireland dilate at the age of 50 years and older, which may have some logic as younger people seem to be more debilitated by drops. We thank the reviewer for this observation and agree that the relevance of this statement required strengthening. We have simplified this section and added the phrase "These changes may affect future practice involvement and patient uptake"
Conclusions: "This study uses staff and patients" experiences of Diabetic Retinopathy Screening to start unpicking factors affecting uptake rates. The successful implementation of the new care pathway should ensure proactive care coordination and consistent strategies to identify and address unmet access needs before, during and after screening. Clear guidance from professional bodies, a Public Health media campaign to encourage positive attitudes, and reformulated mydriasis drops, may improve DRS attendance. Used as an international model, this may, in turn, contribute to reducing preventable vision loss globally and its associated costs to individuals and their families, and to primary, secondary and social care providers" This study uses staff and patients" experiences of Diabetic Retinopathy Screening to start unpicking factors affecting uptake rates which are…. These factors should be addressed in the development and implementation of a new care pathway. "Clear guidance from professional bodies, a Public Health media campaign to encourage positive attitudes, and reformulated mydriasis drops, may improve DRS attendance" You cannot conclude this as you did not study this. These are possible interventions to your identified factors.
Page 13 Conclusions
We thank the reviewer for this suggestion and have added (briefly) which factors we identified, using some of R1"s wording. We have removed the sentence about co-ordinated care, Public Health campaign etc.
REVIEWER 2
May be interesting to include specific set of questions that were asked of patients included in this study as a supplemental figure.
We thank the reviewer for this helpful suggestion and will upload patients & health professionals semistructured interview schedules, as suggested would recommend including in your discussion section of the paper, differences that were noted by patients in regards to screening at GP vs. optometrist practices (e.g. time of appt, ease of making appt, drops, etc) Page 12 1st paragraph We have considered the reviewer"s suggestion and note that participants themselves didn"t notice differences between GP/optometry as they only had experience of one programme -but we did observe differences in our analysis, so we have added "We observed differences between patients screened at GP vs. optometrist practices, identifying that ease of making the appointment, including its time, navigating home after the mydriasis drops, etc. appeared less problematic at GP practices."
Obviously, as the authors point out, this study includes a small subgroup of diabetic patients and only includes certain types of care settings. Also, there is a very high specialist/screener to patient ratio in this study. I would recommend that in your discussion section, you translate your results to include how they relate to real-world screening programs. Page 12 Discussion: Strengths and Limitations paragraph We are unclear about the ratio to which the Reviewer is referring, and feel there has been a misunderstanding of the data provided. We have achieved a fairly even spread of numbers between professional and patient Participants, as detailed in "Characteristics of the sample" on page 5. Our purposive sample did not intend to replicate specialist/screener to patient ratios found in real-world screening programmes. We have added (pg.12) "amongst our Participants" to highlight that we were not trying to be representative/ generalisable.
REVIEWER 3
I agree with the authors that the paper has the limitations expressed within the article. However in addition the study takes a very small sample size and as such only represents the views of a handful of people. Page 12 Discussion: Strengths and Limitations paragraph We thank the reviewer for this comment. We do not, however, agree that 62 participants is a small sample for qualitative research (in fact it is rather more than often found in published studies). We have clarified the role of qualitative analysis on p 12 to help the reader unfamiliar with qualitative research methods, which "highlight socio-cultural meanings of health and illness experiences, not simply their frequency" Nationally a similar exercise should be undertaken amongst programmes preferably at a National level to establish like for like data from region to region.
Much more work is needed is this field so I applaud the initial efforts of the author. 
